Le Roux P D, Samudrala S
Department of Neurosurgery, New York University, New York, USA.
Acta Neurochir (Wien). 1999;141(3):261-7. doi: 10.1007/s007010050296.
Lumbar discectomy is a common elective surgical procedure but many patients still experience postoperative back pain which may delay hospital discharge. We therefore evaluated the efficacy of a parenteral non-steroidal antiinflammatory agent, ketorolac, for the management of post-surgical pain.
Fifty three patients undergoing lumbar discectomy at a Medical School affiliated Veterans Administration hospital were randomly assigned to receive either: 1) 30 mg intramuscular ketorolac upon surgical closure and every 6 hours for 36 hours and narcotic analgesics as needed (PRN); or 2) only narcotic analgesics as needed. A blinded observer recorded the average, minimum and maximum postoperative pain intensity using a Numeric Pain Intensity Scale; total postoperative narcotic consumption, complications, length of hospitalization (from surgery to discharge) and outcome at 6 weeks.
The patients who received ketorolac reported significantly lower average (p < 0.001), minimum (p < 0.001), and maximum (p < 0.001) pain scores than patients receiving only narcotic analgesics. Cumulative narcotic doses (standardized to parenteral morphine) were significantly lower in the ketorolac group (p < 0.001). There was no significant difference between groups in the frequency of side effects, and no complication specifically associated with ketorolac use was observed. Mean length of hospitalization was significantly shorter (p = 0.05) in patients receiving ketorolac than in patients receiving only narcotics. Six weeks after surgery 5 (19.2%) patients who received only narcotics were troubled by persistent back pain. By contrast, all patients who received ketorolac were free of back pain at follow-up (p = 0.03).
These results suggest that ketorolac, when used with PRN narcotics, is more effective than PRN narcotics alone for postoperative pain following lumbar disc surgery. In addition, this strategy also may contribute to early discharge from hospital after lumbar disc surgery.
腰椎间盘切除术是一种常见的择期外科手术,但许多患者术后仍会经历背痛,这可能会延迟出院。因此,我们评估了一种非甾体类抗炎药酮咯酸用于管理术后疼痛的疗效。
在一所医学院附属退伍军人管理局医院接受腰椎间盘切除术的53例患者被随机分配接受以下治疗:1)手术结束时肌肉注射30mg酮咯酸,每6小时一次,共36小时,并根据需要使用麻醉性镇痛药(按需);或2)仅按需使用麻醉性镇痛药。一名盲法观察者使用数字疼痛强度量表记录术后平均、最小和最大疼痛强度;术后麻醉药总消耗量、并发症、住院时间(从手术到出院)以及6周时的结果。
与仅接受麻醉性镇痛药的患者相比,接受酮咯酸的患者报告的平均(p<0.001)、最小(p<0.001)和最大(p<0.001)疼痛评分显著更低。酮咯酸组的累积麻醉药剂量(标准化为胃肠外吗啡)显著更低(p<0.001)。两组在副作用发生频率上无显著差异,且未观察到与使用酮咯酸特别相关的并发症。接受酮咯酸的患者的平均住院时间显著短于仅接受麻醉药的患者(p=0.05)。术后6周,仅接受麻醉药的患者中有5例(19.2%)受到持续性背痛困扰。相比之下,所有接受酮咯酸的患者在随访时均无背痛(p=0.03)。
这些结果表明,酮咯酸与按需使用的麻醉药联合使用时,在腰椎间盘手术后的术后疼痛管理方面比单独按需使用麻醉药更有效。此外,这种策略也可能有助于腰椎间盘手术后早期出院。